SCHEMBL1417873

SCHEMBL1417873

CC(C)(Oc1ccc(Cl)c2ccccc12)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.62
ALDH1A1 P00352 2/20 0.62
HSD17B10 Q99714 1/20 0.62
TSHR P16473 2/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
LMNA P02545 1/20 0.49
KMT2A Q03164 4/20 0.47
PPARA Q07869 3/20 0.47
MEN1 O00255 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
MAPT P10636 1/20 0.47
ESRRA P11474 4/20 0.46
SLC22A12 Q96S37 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12670956 0.82 TSHR (0.51) KDM4EALDH1A1HSD17B10TSHRNPC1
SCHEMBL7988932 0.81 TSHR (0.54) KDM4EALDH1A1HSD17B10TSHRNPC1
Hydrochloric Acid SCHEMBL1417564 0.81 TSHR (0.50) KDM4EALDH1A1HSD17B10TSHRNPC1
SCHEMBL13019803 0.81 CYP1A2 (0.54) KDM4EALDH1A1TSHRNPC1RAB9A
SCHEMBL1046455 0.80 ALDH1A1 (0.60) KDM4EALDH1A1HSD17B10KMT2APPARA
SCHEMBL29195871 0.78 ALDH1A1 (0.58) KDM4EALDH1A1HSD17B10KMT2APPARA
SCHEMBL5822854 0.77 ALDH1A1 (1.00) KDM4EALDH1A1HSD17B10TSHRRAB9A
SCHEMBL11820447 0.77 DUSP3 (0.50) KDM4EALDH1A1HSD17B10TSHRNPC1
SCHEMBL1417733 0.77 TSHR (0.46) KDM4EALDH1A1HSD17B10TSHRNPC1
SCHEMBL21331804 0.75 SLC22A12 (0.48) KDM4EALDH1A1HSD17B10TSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2298747-B1 TRIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC (JP) 2016-12-28 EP disclosed
US-8377923-B2 Triazole derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2013-02-19 US disclosed
US-8377923-B2 Triazole derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2013-02-19 US disclosed
US-8377923-B2 Triazole derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2013-02-19 US disclosed
US-20110105460-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2011-05-05 US disclosed
US-20110105460-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2011-05-05 US disclosed
US-20110105460-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2011-05-05 US disclosed
EP-2298747-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2011-03-23 EP disclosed
WO-2010001946-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF アステラス製薬株式会社 (JP) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105460-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF HSD11B1, HSD11B2, HSD3B1 KDM4E 3912/4885ALDH1A1 359/4885HSD17B10 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.